Chelsey Schroeder
Family · Taylor, MINPI 1164065066
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 224 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,274 and has fallen 83.4% since, to $211 in 2025. Among family clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 224 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$556
- Novo Nordisk$392
- Lilly USA, LLC$315
- Lundbeck LLC$256
- Boehringer Ingelheim$246
- Axsome Therapeutics, Inc.$224
- plus $2K from 25 others
What the payments were for
- Food & beverage$3,643100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $556 |
| Novo Nordisk | 30 | $392 |
| Lilly USA, LLC | 22 | $315 |
| Lundbeck LLC | 18 | $256 |
| Boehringer Ingelheim | 13 | $246 |
| Axsome Therapeutics, Inc. | 8 | $224 |
| AstraZeneca | 9 | $150 |
| Dexcom, Inc. | 8 | $146 |
| Otsuka America Pharmaceutical, Inc. | 8 | $131 |
| Pfizer | 7 | $127 |
| Amarin Pharma, Inc. | 6 | $107 |
| Novartis | 6 | $103 |
| Bayer | 6 | $95 |
| GSK | 6 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $80 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $80 |
| E.r. Squibb & Sons, L.L.C. | 4 | $74 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $55 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $52 |
| Amgen(2 entities) | 3 | $51 |
| Biohaven Pharmaceuticals, Inc. | 3 | $47 |
| Abbott | 3 | $42 |
| Sanofi-aventis U.S. LLC | 3 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Kowa Pharmaceuticals America, Inc. | 3 | $37 |
| Sanofi Pasteur Inc. | 1 | $22 |
| Gilead | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $20 |
| Merck | 1 | $18 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$122
How this compares
$3,643 in reported general payments places this provider in the 90th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Venlafaxine Hcl ErVenlafaxine Hcl | 15 | $547 |
| Buspirone Hcl | 33 | $402 |
| Rosuvastatin Calcium | 22 | $341 |
| Atorvastatin Calcium | 33 | $298 |
| Sertraline Hcl | 34 | $295 |
| Tamsulosin Hcl | 19 | $220 |
| Bupropion XlBupropion Hcl | 21 | $218 |
| Mirtazapine | 18 | $195 |
| Trazodone Hcl | 12 | $183 |
| Losartan Potassium | 11 | $176 |
| Lisinopril | 38 | $151 |
| Levothyroxine Sodium | 14 | $106 |
| Amlodipine Besylate | 19 | $69 |
| Metformin Hcl | 12 | $68 |
Paid to pharmacies, not to this prescriber.
Other family in Taylor
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.